Publications by authors named "Partow Kebriaei"

100Publications

Chimeric Antigen Receptor T-Cells in B-Acute Lymphoblastic Leukemia: State of the Art and Future Directions.

Front Oncol 2020 26;10:1594. Epub 2020 Aug 26.

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2020.01594DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7480185PMC
August 2020

Complete remission in refractory acute lymphoblastic leukemia using blinatumomab after failure of response to CD-19 chimeric antigen receptor T-cell therapy.

Clin Case Rep 2020 Sep 28;8(9):1678-1681. Epub 2020 May 28.

Department of Pediatrics Pediatric Stem Cell Transplantation and Cellular Therapy CARTOX Program The University of Texas MD Anderson Cancer Center Children's Cancer Hospital Houston Texas USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccr3.2918DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7495807PMC
September 2020

Toward a cure in relapsed ALL: we must do better.

Authors:
Partow Kebriaei

Leuk Lymphoma 2020 Aug 11:1-2. Epub 2020 Aug 11.

Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2020.1802455DOI Listing
August 2020

Debate: Transplant Is Still Necessary in the Era of Targeted Cellular Therapy for Acute Lymphoblastic Leukemia.

Clin Lymphoma Myeloma Leuk 2020 Jun 27. Epub 2020 Jun 27.

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2020.06.011DOI Listing
June 2020

Reduced intensity conditioning for acute myeloid leukemia using melphalan- vs busulfan-based regimens: a CIBMTR report.

Blood Adv 2020 Jul;4(13):3180-3190

Center for International Blood and Marrow Transplant Research, Department of Medicine, and.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/bloodadvances.2019001266DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7362362PMC
July 2020

Chimeric Antigen Receptor Therapy: How Are We Driving in Solid Tumors?

Biol Blood Marrow Transplant 2020 Oct 2;26(10):1759-1769. Epub 2020 Jul 2.

Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2020.06.020DOI Listing
October 2020

Haploidentical transplants for patients with relapse after the first allograft.

Am J Hematol 2020 Jul 3. Epub 2020 Jul 3.

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25924DOI Listing
July 2020

Haploidentical transplants for patients with graft failure after the first allograft.

Am J Hematol 2020 Jun 29. Epub 2020 Jun 29.

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25917DOI Listing
June 2020

Chimeric antigen receptor T-cell therapy toxicities.

Br J Clin Pharmacol 2020 May 28. Epub 2020 May 28.

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bcp.14403DOI Listing
May 2020

Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors.

N Engl J Med 2020 02;382(6):545-553

From the Departments of Stem Cell Transplantation and Cellular Therapy (E.L., D.M., P.B., R.B., L.N.K., B.O., M. Kaplan, V.N., I.K., A.N.C., M.D., C.H., P.K., R.M., Y.N., R.C., E.J.S., K.R.), Nuclear Medicine (H.A.M.), Leukemia (P. Thompson, W.W., M. Keating), Biostatistics (P. Thall), Laboratory Medicine (K.C.), Hematopathology (E.N.C.), and Lymphoma and Myeloma (S.N., M.W.), University of Texas M.D. Anderson Cancer Center, Houston.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1910607DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7101242PMC
February 2020

Impact of cytogenetic abnormalities on outcomes of adult Philadelphia-negative acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: a study by the Acute Leukemia Working Committee of the Center for International Blood and Marrow Transplant Research.

Haematologica 2020 05 26;105(5):1329-1338. Epub 2019 Sep 26.

Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota Medical Center, Minneapolis, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2019.220756DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193485PMC
May 2020

Novel Disease Risk Model for Patients with Acute Myeloid Leukemia Receiving Allogeneic Hematopoietic Cell Transplantation.

Biol Blood Marrow Transplant 2020 01 10;26(1):197-203. Epub 2019 Sep 10.

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2019.09.006DOI Listing
January 2020

HLA-DP mismatch and CMV reactivation increase risk of aGVHD independently in recipients of allogeneic stem cell transplant.

Curr Res Transl Med 2019 05 23;67(2):51-55. Epub 2019 Jan 23.

The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.retram.2019.01.001DOI Listing
May 2019

Allotransplants for Patients 65 Years or Older with High-Risk Acute Myeloid Leukemia.

Biol Blood Marrow Transplant 2019 03 9;25(3):505-514. Epub 2018 Oct 9.

Department of Stem Cell Transplantation and Cellular Therapy, MD Anderson Cancer Center, University of Texas, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10838791183059
Publisher Site
http://dx.doi.org/10.1016/j.bbmt.2018.09.032DOI Listing
March 2019

Graft loss attributed to possible transfusion-transmitted ehrlichiosis following cord blood stem cell transplant.

Transpl Infect Dis 2018 Aug 7;20(4):e12899. Epub 2018 May 7.

Department of Infectious Diseases, Infection Control and Employee Health, Division of Internal Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/tid.12899
Publisher Site
http://dx.doi.org/10.1111/tid.12899DOI Listing
August 2018

Early Post-Transplant Minimal Residual Disease Assessment Improves Risk Stratification in Acute Myeloid Leukemia.

Biol Blood Marrow Transplant 2018 07 12;24(7):1514-1520. Epub 2018 Feb 12.

Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2018.02.003DOI Listing
July 2018

Reprint of: Building a Safer and Faster CAR: Seatbelts, Airbags, and CRISPR.

Biol Blood Marrow Transplant 2018 03;24(3S):S15-S19

Center for Cell Engineering and Immunology Program, Memorial Sloan Kettering Cancer Center, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2017.12.789DOI Listing
March 2018

New and emerging therapies for acute and chronic graft host disease.

Ther Adv Hematol 2018 Jan 28;9(1):21-46. Epub 2017 Nov 28.

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 0423, Houston, TX 77030-4000, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2040620717741860DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5753923PMC
January 2018

Building a Safer and Faster CAR: Seatbelts, Airbags, and CRISPR.

Biol Blood Marrow Transplant 2018 01 13;24(1):27-31. Epub 2017 Oct 13.

Center for Cell Engineering and Immunology Program, Memorial Sloan Kettering Cancer Center, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2017.10.017DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5901894PMC
January 2018

Gene Therapy with the Sleeping Beauty Transposon System.

Trends Genet 2017 11 27;33(11):852-870. Epub 2017 Sep 27.

Division of Medical Biotechnology, Paul Ehrlich Institute, Langen, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.tig.2017.08.008DOI Listing
November 2017

Chimeric antigen receptor T-cell therapy - assessment and management of toxicities.

Nat Rev Clin Oncol 2018 Jan 19;15(1):47-62. Epub 2017 Sep 19.

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrclinonc.2017.148DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6733403PMC
January 2018

Etiologies and Impact of Readmission Rates in the First 180 Days After Hematopoietic Stem Cell Transplantation in Children, Adolescents, and Young Adults.

J Pediatr Hematol Oncol 2017 11;39(8):609-613

*Division of Pediatrics Departments of ‡Stem Cell Transplantation and Cellular Therapy §Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX †Department of Pediatrics, The National Cancer Institute, Cairo University, Cairo, Egypt.

View Article

Download full-text PDF

Source
https://journals.lww.com/jpho-online/toc/2017/11000
Web Search
http://Insights.ovid.com/crossref?an=00043426-201711000-0000
Publisher Site
http://dx.doi.org/10.1097/MPH.0000000000000898DOI Listing
November 2017

Impact of Fluid Overload as New Toxicity Category on Hematopoietic Stem Cell Transplantation Outcomes.

Biol Blood Marrow Transplant 2017 Dec 24;23(12):2166-2171. Epub 2017 Aug 24.

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2017.08.021DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5889108PMC
December 2017

Histologic Grade 1 Is Associated With Increased Nonrelapsed Mortality in Lower Gastrointestinal Graft Versus Host Disease.

Am J Surg Pathol 2017 Nov;41(11):1483-1490

Departments of *Stem Cell Transplantation and Cellular Therapy †Pathology ‡Gastroenterology, The University of Texas M.D. Anderson Cancer Center §Department of Pediatric Oncology, Baylor College of Medicine, Houston, TX ∥Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0000000000000914DOI Listing
November 2017

Ex Vivo Mesenchymal Precursor Cell-Expanded Cord Blood Transplantation after Reduced-Intensity Conditioning Regimens Improves Time to Neutrophil Recovery.

Biol Blood Marrow Transplant 2017 Aug 12;23(8):1359-1366. Epub 2017 May 12.

Department of Stem Cell Transplantation and Cellular Therapy, Division of Pathology/Lab Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2017.05.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6453532PMC
August 2017

Manifestations and management of veno-occlusive disease/sinusoidal obstruction syndrome in the era of contemporary therapies.

Clin Adv Hematol Oncol 2017 Feb;15(2):130-139

The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
February 2017

Haploidentical Transplantation with Post-Transplantation Cyclophosphamide for High-Risk Acute Lymphoblastic Leukemia.

Biol Blood Marrow Transplant 2017 Feb 14;23(2):318-324. Epub 2016 Nov 14.

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2016.11.008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5517662PMC
February 2017

Graft-versus-host disease after radiation therapy in patients who have undergone allogeneic stem cell transplantation: two case reports.

J Med Case Rep 2016 Jul 28;10:209. Epub 2016 Jul 28.

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13256-016-0999-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4964004PMC
July 2016

Stem cell transplantation outcomes in lymphoblastic lymphoma.

Leuk Lymphoma 2017 02 27;58(2):366-371. Epub 2016 Jun 27.

a Department of Stem Cell Transplantation and Cellular Therapy , The University of Texas MD Anderson Cancer Center , Houston , TX , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2016.1193860DOI Listing
February 2017